Investor Relations

Message from the
Chairman and CEO

We are working to meet the expectations of our shareholders and investors by enhancing corporate value.

Jun. 03, 2019: World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests-
May. 31, 2019: The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
May. 31, 2019: Notice of the 52nd Ordinary General Meeting of Shareholders
May. 27, 2019: Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field
May. 08, 2019: Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 (PDF：389KB)